Page 1 - hypertension_newsletter3

REFLECTIONS rtensio n
Hype
Hypertension Global Newsletter #3 On behalf of the Scientific Planning CommitteeHype n oisnetr

TABLE OF CONTENTS (SPC), I would like to welcome you back to the third
newsletter in our series where we summarize the
KEY ARTICLES latest clinical and real-world evidence in the field
PATHOPHYSIOLOGY of hypertension and reflect on the clinical impact
Sex differences in arterial hypertension: A of these data on the management of patients
scientific statement from the ESC Council with hypertension. This time we will focus on 1)
on Hypertension, The European Association pathophysiology, 2) CVD risk, and 3) treatment. As
of Preventive Cardiology, Association of always, we invite you to interact with this newsletter
Cardiovascular Nursing and Allied Professions, through links to video summaries of the articles, short
the ESC Council for Cardiology Practice, and clinical perspectives from our SPC, and delve into the
the ESC Working Group on Cardiovascular articles through hyperlinks for in-depth study.
Pharmacotherapy. Gerdts E, et al. Eur J Heart. Prof. Laurent (Chair)
2022; Online Ahead of Print.
Orthostatic hypotension and mortality risk in SCIENTIFIC PLANNING COMMITTEE
geriatric outpatients: The impact of duration and
magnitude of the blood pressure drop. Wiersinga Prof. Stéphane Laurent
JHI, et al. J Hypertens. 2022 Jun 1;40(6):1107-1114 (France)
CARDIOVASCULAR DISEASE RISK
Growing heart failure burden of Prof. Adriana Camargo
hypertensive heart disease: A call to action. (Brazil)
Díez J, Butler J. Hypertension. 2022 Sep
9:101161HYPERTENSIONAHA12219373. Online Prof. Adolfo Chavez
ahead of print. (Mexico)
Childhood cardiovascular risk factors and adult
cardiovascular events. Jacobs DR Jr, et al. N Engl Prof. Wei Sun
J Med. 2022 May 19;386(20):1877-1888. (China)
TREATMENT
Bedtime dosing of antihypertensive Prof. Nqoba Tsabedze
medications: Systematic review and consensus (South Africa)
statement: International Society of Hypertension
position paper endorsed by World Hypertension Prof. Svetlana Villevalde
League and European Society of Hypertension. (Russia)
Stergiou G, et al. J Hypertens. 2022 Oct
1;40(10):1847-1858.
Comparative safety and effectiveness
of aldosterone antagonists versus beta-
blockers as fourth agents in patients with
apparent resistant hypertension. Desai R, et al.
Hypertension. 2022 Oct;79(10):2305-2315.
Blood pressure lowering and prevention of
dementia: An individual patient data meta-
analysis. Peters R, et al. Eur Heart J. 2022 Oct
25;ehac584.

ADDITIONAL ARTICLES OF INTEREST